ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Osteoarthritis"

  • Abstract Number: 2388 • 2015 ACR/ARHP Annual Meeting

    Variations in Hip Morphology Are Associated with Hip Symptoms: Preliminary Results from a Large Community-Based Cohort

    Amanda E. Nelson1, Jamie L. Stiller1, Xiaoyan A. Shi1,2, Jordan B. Renner3, Todd A. Schwartz4, Nigel K Arden5 and Joanne M. Jordan1, 1Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, 2SAS Institute, Inc, Cary, NC, 3Radiology, University of North Carolina, Chapel Hill, NC, 4School of Nursing, University of North Carolina, Chapel Hill, NC, 5Oxford NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, United Kingdom

    Background/Purpose: Alterations in hip morphology, such as femoroacetabular impingement, have been associated with incident hip OA and total hip replacement (THR), but associations of these…
  • Abstract Number: 452 • 2015 ACR/ARHP Annual Meeting

    Associations Between Arthritis Patient, Disease-Specific and Provider Characteristics and Medication Information Source Use

    Lorie Geryk1, Susan J. Blalock2, Robert DeVellis3, Joanne M. Jordan3 and Delesha Carpenter4, 1Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, 2Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 3Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, 4Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Asheville, NC

    Background/Purpose: Few studies have described how patient, disease-specific, and provider factors are associated with medication information source use among arthritis patients. We address this research…
  • Abstract Number: 2394 • 2015 ACR/ARHP Annual Meeting

    B-Flow Imaging of Synovial Tissue in Osteoarthritis

    Ralf G. Thiele1, Allen P. Anandarajah2 and Christopher T. Ritchlin3, 1University of Rochester Medical Center, Rochester, NY, 2Dept of Rheumatology, Univ of Rochester Medical Ctr, Rochester, NY, 3Allergy, Immunology and Rheumatololgy Division, University of Rochester Medical Center, Rochester, NY

    Background/Purpose: Development of disease modifying medication for osteoarthritis (OA) is desirable, but the target tissue of such treatment remains unclear. We have previously shown that…
  • Abstract Number: 534 • 2015 ACR/ARHP Annual Meeting

    Antibodies to Malondialdehyde-Acetaldehyde Adducts Are Highly Expressed in Rheumatoid Arthritis Synovial Fluid 

    Rafid Rahman1, Geoffrey M. Thiele2, Andy Hollins3, Michael J. Duryee1, Daniel Anderson3, Bartlett Hamilton4, Kaleb Michaud5, Lynell W. Klassen6 and Ted R. Mikuls3, 1Internal Medicine Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, 2Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 3University of Nebraska Medical Center, Omaha, NE, 4University of Nebraska Medical Center and Omaha VA Medical Center, Omaha, NE, 5Rheumatology & Immunology, University of Nebraska Medical Center and National Data Base for Rheumatic Diseases, Omaha, NE, 6Dept of Internal Medicine, Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE

    Background/Purpose:   Malondialdehyde-acetaldehyde (MAA) adducts are expressed in synovial tissues in rheumatoid arthritis (RA). Post-translational MAA modifications are pro-inflammatory, promoting robust anti-MAA antibody responses that…
  • Abstract Number: 2407 • 2015 ACR/ARHP Annual Meeting

    Comparison of Knee Osteoarthritis Treatment in the Non-Obese Versus Obese Populations Across Different Medical Specialties

    Kelly Forrester1, Farah Taufiq1 and Jonathan Samuels2,3, 1NYU Langone Medical Center, New York, NY, 2Rheumatology, NYU - Hospital for Joint Diseases, New York, NY, 3Rheumatology, NYU Langone Medical Center, New York, NY

    Background/Purpose:   Knee osteoarthritis (KOA) in the obese population is underdiagnosed and routinely undertreated, as providers often attribute pain to excess weight without considering articular…
  • Abstract Number: 897 • 2015 ACR/ARHP Annual Meeting

    Intra-Articular Corticosteroids Are Safe and Have No Major Effect on Structural Progression of Synovitic Knee OA: A 2-Year Randomized Controlled Trial of 3-Monthly Triamcinolone Hexacetonide

    Jeffrey Driban1, Michael P. Lavalley2, Lori Lyn Price3, William F. Harvey4 and Timothy E. McAlindon4, 1Tufts Medical Center, Boston, MA, 2Biostatistics, Boston University, Boston, MA, 3Clinical Care Research, Tufts Medical Center, Boston, MA, 4Rheumatology, Tufts Medical Center, Boston, MA

    Background/Purpose: Synovitis is common in knees with OA, and is associated with structural progression. Intra-articular corticosteroids are widely used and could reduce knee OA cartilage…
  • Abstract Number: 2409 • 2015 ACR/ARHP Annual Meeting

    Factors Associated with Physical Therapy Use in Osteoarthritis of the Knee: Results from a Population-Based Study

    Sicong Huang1, Eric C. Sayre2 and Jolanda Cibere1,2, 1Department of Medicine, University of British Columbia, Vancouver, BC, Canada, 2Arthritis Research Canada, Richmond, BC, Canada

    Background/Purpose: Osteoarthritis (OA) is the most common form of arthritis. Physical therapy (PT) has previously been demonstrated to benefit patients with osteoarthritis, especially with early…
  • Abstract Number: 1291 • 2014 ACR/ARHP Annual Meeting

    Relationships Between Inflammation, Disease Severity and Synovial Fluid Calcium Crystals Detected By Scanning Electronic Microscopy in Early Osteoarthritis

    Paola Frallonardo1, Francesca Oliviero1, Luca Peruzzo2, Leonardo Tauro3, Anna Scanu1, Mariagrazia Lorenzin1, Augusta Ortolan1, Leonardo Punzi4 and Roberta Ramonda1, 1Rheumatology Unit, Department of Medicine, University of Padova, Padova, Italy, 2Institute for Geosciences and Earth Resources IGG-CNR, Padova, Italy, 3Department of Geosciences, University of Padova, Padova, Italy, 4Department of Medicine - DIMED, University of Padova, Padova, Italy

    Background/Purpose The presence of calcium crystals (CC) in synovial fluid (SF) of osteoarthritis (OA) is a well known and frequent feature (1). However, their role…
  • Abstract Number: 108 • 2014 ACR/ARHP Annual Meeting

    Patient Reported Outcomes Following Total Knee Arthroplasty in Rheumatoid Arthritis and Osteoarthritis

    Anand Dusad1, Sofia Pedro2, Kevin Garvin3, Curtis Hartman4, James O'Dell5, Ted R. Mikuls5 and Kaleb Michaud6, 1Rheumatology, University of Nebraska Medical Center, Omaha, NE, 2National Data Bank for Rheumatic Diseases, Wichita, KS, 3Orthopaedic Surgery, University of Nebraska Medical Center, Omaha, NE, 4Orthopaedic Surgery and Rehabilitation, University of Nebraska Medical Center, Omaha, NE, 5University of Nebraska Medical Center, Omaha, NE, 6University of Nebraska Medical Center and National Data Bank, Omaha, NE

    Background/Purpose: Due to the progressive and debilitating nature of knee arthritis, total knee arthroplasty (TKA) is the ultimate outcome. TKA is an effective surgical intervention…
  • Abstract Number: 1284 • 2014 ACR/ARHP Annual Meeting

    Sensitivity to Change of Patient Preference Outcome Measures for Pain in Trials of Patients with Knee Osteoarthritis

    Matthew J. Parkes1, Michael J. Callaghan1, Terence W. O'Neill1 and David T. Felson1,2, 1Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, University of Manchester, Manchester, United Kingdom, 2Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA

    Background/Purpose A variety of pain and function instruments are often measured in osteoarthritis (OA) clinical trials. Instruments with maximal sensitivity to change are preferred as the…
  • Abstract Number: 76 • 2014 ACR/ARHP Annual Meeting

    Identification of Synovial Genes and Pathways Associated with Disease Progression in a Cohort of Early Symptomatic Osteoarthritis Patients Using a Transcriptomic Approach

    Arjen B. Blom1, Peter L. van Lent1, Martijn H. van den Bosch2, Hans Cats3, Frank H.J. van den Hoogen4, Floris P.J.G. Lafeber5, Wim B. van den Berg1 and Peter M. van der Kraan1, 1Experimental Rheumatology, Radboud university medical center, Nijmegen, Netherlands, 2Experimental Rheumatology (272), Radboud university medical center, Nijmegen, Netherlands, 3Hengstdal 3, Sint Maartenskliniek, Ubbergen, Netherlands, 4Rheumatology, Rheumatology Centre Sint Maartenskliniek and Radboud university medical center, Ubbergen (Nijmegen), Netherlands, 5Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands

    Background/Purpose: If and how the synovial activation that is observed in over 50% of osteoarthritis (OA) patients contributes to irreversible joint pathology, is not known.…
  • Abstract Number: 1285 • 2014 ACR/ARHP Annual Meeting

    Prevalence of Risk Factors for Gastrointestinal Side Effects of Drugs for the Treatment of Pain in Rheumatic Diseases and the Provision of Gastroprotective Treatment – Results of a Large Non-Intervention Study

    Gustavo Citera1, Edgardo Smecuol2, Alberto Millán3, Manuel Robles4 and Ruben Mantilla5, 1Universidad de Buenos Aires, Buenos Aires, Argentina, 2Hospital Municipal de Gastroenterología, Buenos Aires, Argentina, 3Hospital Universitario de Caracas, Caracas, Venezuela, 4Centro Médico Toluca, Toluca, Mexico, 5Clínica de Artritis y Rehabilitación (CAYRE), Bogota, Colombia

    Background/Purpose: Non-steroidal anti-inflammatory drugs (NSAIDs) are the long established first-line treatment for the management of pain associated with rheumatic diseases but carry a risk of…
  • Abstract Number: 68 • 2014 ACR/ARHP Annual Meeting

    Physical Inactivity to Activity Associated with Less Decline in Physical Function

    Abigail Gilbert1, Jing Song2, Pamela A. Semanik3, Rowland W. Chang4 and Dorothy D. Dunlop2, 1Rheumatology, Northwestern University, Chicago, IL, 2Northwestern University Feinberg School of Medicine, Chicago, IL, 3Northwestern University, Chicago, IL, 4Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: Regular physical activity has been demonstrated to improve quality of life for adults with chronic disease including osteoarthritis. Despite these benefits, half of adults…
  • Abstract Number: 2969 • 2014 ACR/ARHP Annual Meeting

    Mortality after Knee Replacement Surgery for Osteoarthritis in a Population-Based Propensity-Score Matched Cohort

    Devyani Misra1, Tuhina Neogi2, Na Lu3, David T. Felson3, Thomas Einhorn4, Hyon K. Choi5, Jessica Maxwell6 and Yuqing Zhang3, 1Rheumatology, Boston University School of Medicine, Boston, MA, 2Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 3Boston University School of Medicine, Boston, MA, 4Orthopedics, Boston University School of Medicine, Boston, MA, 5Division of Rheumatology, Allergy, and Immunology Massachusetts General Hospital, Harvard Medical School, Boston, MA, 6Physical Therapy & Athletic Training, Boston University, Boston, MA

    Background/Purpose : Knee replacement (KR) surgery for osteoarthritis (OA) provides improvement in symptoms and function. Whether these improvements translate into survival benefit has been unclear,…
  • Abstract Number: 1088 • 2014 ACR/ARHP Annual Meeting

    Socioeconomic Disparities in Health Outcomes Among Individuals with, or at Risk for, Osteoarthritis from the United States: Data from the Osteoarthritis Initiative

    Antoine A. Baldassari1, Todd Schwartz1, Rebecca J. Cleveland1, Joanne M. Jordan2 and Leigh F. Callahan3, 1Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 2University of North Carolina Dept of Epidemiology, Chapel Hill, NC, 3Thurston Arthritis Res Ctr, University of North Carolina, Chapel Hill, NC

    Background/Purpose Socioeconomic disparities in health outcomes among people with osteoarthritis are well documented, with some key limitations: existing studies limit their analyses to few outcome…
  • « Previous Page
  • 1
  • …
  • 53
  • 54
  • 55
  • 56
  • 57
  • …
  • 63
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology